Patient characteristics and treatment modalities
Characteristics | |
---|---|
Number of patients | 60 |
Mean age, yrs ± SD | 62.34 ± 9.18 |
Sex | |
Male | 49 (81.7%) |
Female | 11 (18.3%) |
Primary tumor site | |
Base of tongue | 24 (40.0%) |
Tonsil | 14 (23.3%) |
Larynx | 7 (11.7%) |
Less common/unknown sites | 15 (25.0%) |
T staging | |
Tx | 14 (23.3%) |
T0 | 2 (3.3%) |
T1 | 2 (3.3%) |
T2 | 15 (25.0%) |
T3 | 9 (15.0%) |
T4 | 18 (30.0%) |
N staging | |
N1 | 2 (3.3%) |
N2 | 51 (85.0%) |
N3 | 7 (11.7%) |
M staging | |
M0 | 60 (100%) |
p16 expression | |
Positive | 21 (35.0%) |
Negative | 11 (18.3%) |
Unknown (insufficient specimen) | 28 (46.7%) |
Treatment | |
Radiotherapy + concurrent chemotherapy | 39 (65.0%) |
Induction chemotherapy + radiotherapy + concurrent chemotherapy | 21 (35.0%) |